Literature DB >> 21375911

Placebo treatment in mild to moderate depression.

Rudiger Pittrof.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21375911      PMCID： PMC3047320          DOI： 10.3399/bjgp11X561285

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  4 in total

Review 1.  Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression.

Authors:  Joel R Sneed; Bret R Rutherford; David Rindskopf; David T Lane; Harold A Sackeim; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2007-11-12       Impact factor: 4.105

Review 2.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

Review 3.  The persistence of the placebo response in antidepressant clinical trials.

Authors:  Arif Khan; Nick Redding; Walter A Brown
Journal:  J Psychiatr Res       Date:  2007-11-26       Impact factor: 4.791

4.  Folate augmentation of treatment - evaluation for depression (FolATED): protocol of a randomised controlled trial.

Authors:  Seren Haf Roberts; Emma Bedson; Dyfrig Hughes; Keith Lloyd; David B Menkes; Stuart Moat; Munir Pirmohamed; Gary Slegg; Johannes Thome; Richard Tranter; Rhiannon Whitaker; Clare Wilkinson; Ian Russell
Journal:  BMC Psychiatry       Date:  2007-11-15       Impact factor: 3.630
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.